{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:23:16Z","timestamp":1794604996238,"version":"4.9.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    This study aimed to evaluate ventilator requirements, gas exchange, and safety outcomes before and after initiation of continuous infusion ketamine in intubated patients with severe asthma exacerbations (SAEs) in ICUs. This retrospective observational study included 38 intubated patients 18 years old or older experiencing an SAE who received a continuous infusion of ketamine for greater than or equal to 1 hour. The primary outcome was change in P\n                    <jats:sc>co<\/jats:sc>\n                    <jats:sub>2<\/jats:sub>\n                    before and after ketamine initiation. The median P\n                    <jats:sc>co<\/jats:sc>\n                    <jats:sub>2<\/jats:sub>\n                    before ketamine initiation was 67.65\u2009mm Hg (56\u201381\u2009mm Hg) and 64\u2009mm Hg (56\u201377\u2009mm Hg) after. The median pH before and after ketamine initiation was 7.21 (7.12\u20137.3) and 7.24 (7.14\u20137.3), respectively. The median maximum rate of ketamine was 1.2\u2009mg\/kg\/hr (0.7\u20131.5\u2009mg\/kg\/hr). Mortality occurred in 15.8% of patients. Tachycardia occurred in 52.6% of patients, and hypotension occurred in 50% of patients. The rate of emergence reactions was 13.2%. In this study, continuous infusion ketamine was not associated with an improvement in P\n                    <jats:sc>co<\/jats:sc>\n                    <jats:sub>2<\/jats:sub>\n                    .\n                  <\/jats:p>","DOI":"10.1097\/cce.0000000000001346","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:00:37Z","timestamp":1767978037000},"page":"e1346","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Ketamine for Severe Asthma Exacerbation"],"prefix":"10.1097","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0586-4998","authenticated-orcid":false,"given":"Emily M.","family":"Wagner","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen L.","family":"Sacha","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mireles-Cabodevila","sequence":"additional","affiliation":[{"name":"Respiratory Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Mujanovic","sequence":"additional","affiliation":[{"name":"Respiratory Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Torbic","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chest.2022.02.029","article-title":"Management of life-threatening asthma: Severe asthma series.","volume":"162","author":"Garner","year":"2022","journal-title":"Chest"},{"key":"R2-20260109","first-page":"e21","article-title":"The effect of low-dose ketamine in treating acute asthma attack; a randomized clinical trial.","volume":"6","author":"Esmailian","year":"2018","journal-title":"Emerg (Tehran)"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5114\/ait.2020.97765","article-title":"Negative results for ketamine use in severe acute bronchospasm: A randomised controlled trial.","volume":"52","author":"Nedel","year":"2020","journal-title":"Anaesthesiol Intensive Ther"},{"key":"R4-20260109","first-page":"175","article-title":"Use of ketamine in severe status asthmaticus in intensive care unit.","volume":"2","author":"Heshmati","year":"2003","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.annemergmed.2005.02.024","article-title":"The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma.","volume":"46","author":"Allen","year":"2005","journal-title":"Ann Emerg Med"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0196-0644(96)70319-0","article-title":"Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma.","volume":"27","author":"Howton","year":"1996","journal-title":"Ann Emerg Med"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1081\/JAS-100107543","article-title":"Emergency department use of ketamine in pediatric status asthmaticus.","volume":"38","author":"Petrillo","year":"2001","journal-title":"J Asthma"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/1817-1737.191874","article-title":"Ketamine versus aminophylline for acute asthma in children: A randomized, controlled trial.","volume":"11","author":"Tiwari","year":"2016","journal-title":"Ann Thorac Med"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00228-022-03374-3","article-title":"Use of ketamine in patients with refractory severe asthma exacerbations: Systematic review of prospective studies.","volume":"78","author":"La","year":"2022","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:00:39Z","timestamp":1767978039000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":9,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000001346","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}